Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein

Jing Zhang1, Bifeng Yuan, Fan Zhang

  • 1Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an 710062, P. R. China.

Insights

Cyclophosphamide temporarily increases global DNA cytosine methylation in leukemia cells by affecting DNMT1 protein stability. This epigenetic alteration in cancer cells returns to normal levels after 8 days.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Pharmacology

Background:

  • Aberrant DNA cytosine methylation is a hallmark of cancer development.
  • Chemotherapeutic agents can influence epigenetic modifications, impacting cancer progression.
  • Understanding these drug-induced epigenetic changes is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the effects of common chemotherapeutic agents on DNA cytosine methylation in Jurkat-T acute lymphoblastic leukemia cells.
  • To identify which agents cause the most significant perturbations in global DNA methylation.
  • To elucidate the molecular mechanisms underlying drug-induced methylation changes.

Main Methods:

  • Treatment of Jurkat-T cells with six different antitumor agents.
  • Assessment of global DNA cytosine methylation levels over time.
  • Analysis of DNA methyltransferase 1 (DNMT1) protein and mRNA expression.
  • Investigation of DNMT1 protein stability regulation by lysine methylation and associated enzymes like LSD1.

Main Results:

  • Cyclophosphamide induced the most significant increase in global DNA cytosine methylation after 24 hours.
  • Long-term cyclophosphamide treatment showed a time-dependent increase in methylation, returning to normal by day 8.
  • Increased DNMT1 protein levels correlated with increased LSD1 protein and decreased DNMT1 K142 methylation.
  • DNMT1 mRNA levels did not significantly increase, suggesting post-transcriptional regulation.

Conclusions:

  • Cyclophosphamide temporarily alters global DNA cytosine methylation in leukemia cells.
  • The observed changes are mediated by the regulation of DNMT1 protein stability through lysine methylation.
  • These findings highlight a novel mechanism by which chemotherapy impacts epigenetic regulation in cancer cells.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...